119 related articles for article (PubMed ID: 2387019)
1. Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Hébert CD; Cao QL; Birnbaum LS
Carcinogenesis; 1990 Aug; 11(8):1335-42. PubMed ID: 2387019
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells.
Hébert CD; Cao QL; Birnbaum LS
Cancer Res; 1990 Nov; 50(22):7190-7. PubMed ID: 2171758
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
4. Growth stimulation of primary rat hepatocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wölfle D; Becker E; Schmutte C
Cell Biol Toxicol; 1993; 9(1):15-31. PubMed ID: 8100183
[TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line.
Hudson LG; Toscano WA; Greenlee WF
Toxicol Appl Pharmacol; 1986 Mar; 82(3):481-92. PubMed ID: 3952731
[TBL] [Abstract][Full Text] [Related]
6. Reversible inhibition of in vitro epithelial cell proliferation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Gierthy JF; Crane D
Toxicol Appl Pharmacol; 1984 Jun; 74(1):91-8. PubMed ID: 6729824
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells.
Osborne R; Greenlee WF
Toxicol Appl Pharmacol; 1985 Mar; 77(3):434-43. PubMed ID: 2579475
[TBL] [Abstract][Full Text] [Related]
8. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone on growth and differentiation of cultured malignant human keratinocytes.
Rice RH; Cline PR
Carcinogenesis; 1984 Mar; 5(3):367-71. PubMed ID: 6200249
[TBL] [Abstract][Full Text] [Related]
10. Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Stohs SJ; Abbott BD; Lin FH; Birnbaum LS
Toxicology; 1990 Dec; 65(1-2):123-36. PubMed ID: 2274963
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.
Rowlands C; Krishnan V; Wang X; Santostefano M; Safe S; Miller WR; Langdon S
Cancer Res; 1993 Apr; 53(8):1802-7. PubMed ID: 8385571
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
van Duursen MB; Sanderson JT; van den Berg M
Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
[TBL] [Abstract][Full Text] [Related]
13. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro.
Lang DS; Becker S; Clark GC; Devlin RB; Koren HS
Arch Toxicol; 1994; 68(5):296-302. PubMed ID: 8085940
[TBL] [Abstract][Full Text] [Related]
14. Interactive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoids on proliferation and differentiation in cultured human keratinocytes: quantification of cross-linked envelope formation.
Berkers JA; Hassing I; Spenkelink B; Brouwer A; Blaauboer BJ
Arch Toxicol; 1995; 69(6):368-78. PubMed ID: 7495374
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Gaido KW; Maness SC
Toxicol Appl Pharmacol; 1994 Aug; 127(2):199-208. PubMed ID: 8048063
[TBL] [Abstract][Full Text] [Related]
16. Uroporphyrin accumulation associated with cytochrome P4501A induction in fish hepatoma cells exposed to aryl hydrocarbon receptor agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin and planar chlorobiphenyls.
Hahn ME; Chandran K
Arch Biochem Biophys; 1996 May; 329(2):163-74. PubMed ID: 8638948
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of chlorinated aromatic compounds in animals and humans: in vitro approaches to toxic mechanisms and risk assessment.
Greenlee WF; Osborne R; Dold KM; Hudson LG; Toscano WA
Environ Health Perspect; 1985 May; 60():69-76. PubMed ID: 2992929
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
19. TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells.
Abbott BD; Birnbaum LS
Teratology; 1991 Feb; 43(2):119-32. PubMed ID: 2014478
[TBL] [Abstract][Full Text] [Related]
20. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.
Wood SC; Jeong HG; Morris DL; Holsapple MP
Toxicology; 1993 Jul; 81(2):131-43. PubMed ID: 8378939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
